Desmopressin during complex sellar tumor surgery
Treatments studied
Part of Cancer clinical trials.
This trial tests whether giving desmopressin (a drug that helps the body hold onto water) during surgery can prevent fluid and sodium balance problems in people having complex pituitary or sellar region tumor surgery. It’s designed for those at higher risk of these issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have a sellar region tumor (like craniopharyngioma or pituitary adenoma) that needs surgery.
- You have at least two of these: diabetes insipidus, a large tumor, a tumor close to the pituitary stalk, or surgery lasting over 4 hours.
- You can stop certain medications (like water pills or antipsychotics) before surgery.
- You don't have serious kidney, heart, or hormone problems, low sodium, or allergies to the trial drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving DDAVP before a PET scan can help doctors better locate the pituitary problem in people with Cushing disease. It may help confirm where the ACTH-producing tumor is so surgery can be planned more accurately.
This trial is for people who have both a tumor in the sellar region (an area near the center of the brain) and an unruptured brain aneurysm (a bulging blood vessel that hasn't burst). It tests different treatments, like surgery or observation, to see what works best. If you have these conditions and haven't had treatment yet, you might be able to join.
This study tests whether a medicine called desmopressin (DDAVP) can reduce bleeding during heart surgery. It uses a special blood test (TEG6) to decide who gets the medicine.
This study tests whether a protein supplement combined with drinking less fluid can help keep sodium levels stable after pituitary surgery. It is designed for patients who are at risk of sodium imbalances after their operation.
This trial tests a medication called DDAVP to prevent the sodium level from rising too quickly when treating severe low sodium in ICU patients. It is for those with dangerously low sodium and neurological symptoms, but without certain other medical conditions.
This trial is testing a drug called desmopressin to see if it can reduce the need for blood transfusions in patients at high risk of bleeding during heart surgery. If you qualify, you may be randomly assigned to receive the drug or a placebo (a dummy treatment) during surgery, and the study will monitor how much blood you need.
Hear when a new Craniopharyngiomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.